[1]
|
李冰. 非小细胞肺癌的综合诊治策略——NCCN肿瘤学临床实践指南(2006第二版)评析[J]. 医学与哲学, 2007, 28(14): 66-67.
|
[2]
|
Gozuacik, D., Akkoc, Y., Ozturk, D.G., et al. (2017) Autophagy-Regulating microRNAs and Cancer. Frontiers in Oncology, 7, 65. https://doi.org/10.3389/fonc.2017.00065
|
[3]
|
Valentina, F.L., Ami, N.I., Jiang, W.G. and Cui, Y. (2017) Therapeutic Role of miR-140 for the Treatment of Non-small Cell Lung Cancer. Anticancer Research, 37, 4319-4327.
|
[4]
|
Jeong, H.C. (2014) Clinical Aspect of MicroRNA in Lung Cancer. Tuberculosis & Respiratory Diseases, 77, 60-64.
https://doi.org/10.4046/trd.2014.77.2.60
|
[5]
|
Lee, R.C., Feinbaum, R.L., Ambros, V., et al. (1993) The C. elegans Heterochronicgene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell, 75, 843-854. https://doi.org/10.1016/0092-8674(93)90529-Y
|
[6]
|
Scott, G.K., Goga, A., Bhaumik, D., et al. (2006) Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-l25a or miR-125b. The Journal of Biological Chemistry, 282, 1479-1486.
https://doi.org/10.1074/jbc.M609383200
|
[7]
|
Finnegan, E.J. and Matzke, M.A. (2003) The Small RNA World. Journal of Cell Science, 116, 4689-4693.
|
[8]
|
Garzon, R. and Croce, C.M. (2008) miRNAs in Normal and Malignant Hematopoiesis. Current Opinion in Hematology, 15, 352-358. https://doi.org/10.1097/MOH.0b013e328303e15d
|
[9]
|
Ventura, A. and Jacks, T. (2009) miRNAs and Cancer: Short RNAs Go a Long Way. Cell, 136, 586-591.
|
[10]
|
Kumar, M.S., Erkeland, S.J., Pester, R.E., Chen, C.Y., Ebert, M.S., et al. (2008) Suppression of Non-Small Cell Lung Tumor Development by the Let-7 miRNA Family. Proceedings of the National Academy of Sciences of the United States of America, 105, 3903-3908. https://doi.org/10.1073/pnas.0712321105
|
[11]
|
Usufović, E., Rijavec, M., Keser, D., Korošec, P., Sodja, E., et al. (2012) let-7b and miR-126 Are Down-Regulated in Tumor Tissue and Correlate with Microvessel Density and Survival Outcomes in non-Small-Cell Lung Cancer. PLOS ONE, 7, e45577. https://doi.org/10.1371/journal.pone.0045577
|
[12]
|
Schliekelman, M.J., Gibbons, D.L., Faca, V.M., Creighton, C.J., Rizvi, Z.H., et al. (2011) Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial-Mesenchymal Transition in Cancer. Cancer Research, 71, 7670-7682.
https://doi.org/10.1158/0008-5472.CAN-11-0964
|
[13]
|
Wang, J., Tian, X., Han, R., Zhang, X., Wang, X., et al. (2013) Downregulation of miR-486-5p Contributes to Tumor Progression and Metastasis by Targeting Protumorigenic ARHGAP5 in Lung Cancer. Oncogene. [Epub ahead of print]. PubMed: 23474761.
|
[14]
|
Chen, G., Umelo, I.A., Lv, S., Teugels, E., Fostier, K., et al. (2013) miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells. PLOS ONE, 8, e60317.
https://doi.org/10.1371/journal.pone.0060317
|
[15]
|
Liu, X., Sempere, L.F., Ouyang, H., Memoli, V.A., Andrew, A.S., et al. (2010) miRNA-31 Functions as an Oncogenic miRNA in Mouse and Human Lung Cancer Cells by Repressing Specific Tumor Suppressors. Journal of Clinical Investigation, 120, 1298-1309. https://doi.org/10.1172/JCI39566
|
[16]
|
Li, Y., Zhang, D., Chen, C., Ruan, Z., Li, Y., et al. (2012) miRNA-212 Displays Tumor-Promoting Properties in Non-Small Cell Lung Cancer Cells and Targets the Hedgehog Pathway Receptor PTCH1. Molecular Biology of the Cell, 23, 1423-1434. https://doi.org/10.1091/mbc.e11-09-0777
|
[17]
|
Liu, X.H., Lu, K.H., Wang, K.M., Sun, M., Zhang, E.B., et al. (2012) miRNA-196a Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion through Targeting HOXA5. BMC Cancer, 12, 348.
https://doi.org/10.1186/1471-2407-12-348
|
[18]
|
Zhang, H.T., Chen, X.F., Wang, M.H., et al. (2004) Defective Expression of Transforming Growth Factor Beta Receptor Type II Is Associated with Cp G Methylated Promoter in Primary Non-Small Cell Lung Cancer. Clinical Cancer Research, 10, 2359-2367.
|
[19]
|
Milani, L., Lundmark, A., Nordlund, J., et al. (2009) Allele-Specific Gene Expression Patterns in Primary Leukemic Cells Reveal Regulation of Gene Expression by Cp G Site Methylation. Genome Research, 19, 1-11.
|
[20]
|
张延霞. miR-21/miR-140/miR-206在肺腺癌发病中的作用研究[D]: [硕士学位论文]. 烟台: 滨州医学院, 2013.
|
[21]
|
Chen, H.Y., Yu, S.L., Chen, C.H., Chang, G.C., Chen, C.Y., Yuan, A., et al. (2007) A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 356, 11-20.
https://doi.org/10.1056/NEJMoa060096
|
[22]
|
Li, W. and He, F. (2014) Monocyte to Macrophage Differentiation-Associated (MMD) Targeted by miR-140 Regulates Tumor Growth in Non-Small Cell Lung Cancer. Biochemical and Biophysical Research Communications, 450, 844-850. https://doi.org/10.1016/j.bbrc.2014.06.075
|
[23]
|
Liu, Q., Zheng, J., Yin, D.D., Xiang, J., He, F., Wang, Y.C., et al. (2012) Monocyte to Macrophage Differentiation-Associated (MMD) Positively Regulates ERK and Akt Activation and TNF-a and No Production in Macrophages. Molecular Biology Reports, 39, 5643-5650. https://doi.org/10.1007/s11033-011-1370-5
|
[24]
|
Reddi, A.H. (1998) Role of Morphogenetic Proteins in Skeletal Tissue Engineering and Regeneration.
|
[25]
|
Yang, R., Zhang, D., Yu, K., et al. (2018) Detection of miR-22, miR-140 and Bone Morphogenetic Proteins (BMP)-2 Expression Levels in Synovial Fluid of Osteoarthritis Patients before and after Arthroscopic Debridement. Medical Science Monitor International Medical Journal of Experimental & Clinical Research, 24, 863-868.
https://doi.org/10.12659/MSM.908110
|
[26]
|
Depinho, R. (2000) The Age of Cancer. Nature, 408, 248-254. https://doi.org/10.1038/35041694
|
[27]
|
Megyesi, K., Kahn, C.R., Roth, J., et al. (1975) The NSILA-s Receptor in Liver Plasma Membranes. Characterization and Comparison with the Insulin Receptor. The Journal of Biological Chemistry, 250, 8990-8996.
|
[28]
|
Bhaumick, B., Bala, R.M. And Hollenberg, M.D. (1981) Somatomedin Receptor of Human Placenta: Lubilization, Photolabeling, Partial Purification and Comparison with Insulin Receptor. Proceedings of the National Academy of Sciences of the United States, 78, 4279-4283. https://doi.org/10.1073/pnas.78.7.4279
|
[29]
|
Yuan, Y., Shen, Y., Xue, L., et al. (2013) miR-140 Suppresses Tumor Growth and Metastasis of Nonsmall Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor. PLoS ONE, 8, e73604.
https://doi.org/10.1371/journal.pone.0073604
|
[30]
|
Lorio, M.V., Ferracin, M., Liu, C.G., et al. (2005) MicroRNA Gene Expression Deregulation in Human Breast Cancer. Cancer Research, 65, 7065-7070. https://doi.org/10.1158/0008-5472.CAN-05-1783
|
[31]
|
Yan, I.X., Huang, X.F., Shao, Q., et al. (2008) MieroRNA miR-21 Overexpression in Human Breast Cancer Is Associated with Advanced Clinical Stage, Lymph Node Metastasis and Patient Poor Prognosis. RNA, 14, 2348-2360.
https://doi.org/10.1261/rna.1034808
|
[32]
|
Zhang, Y., Eades, G., Yao, Y., et al. (2012) Estrogen Receptor Alpha Signaling Regulates Breast Tumor Initiating Ceils by Downregulating miR-140 Which Targets the Transcription Factor SOX2. The Journal of Biological Chemistry, 287, 41514-41522. https://doi.org/10.1074/jbc.M112.404871
|
[33]
|
于影, 李豪杰, 温传俊. MicroRNA-140在乳腺癌细胞中对Nrf2及其下游抗氧化基因的表达调控[J]. 国际免疫学杂志, 2013, 36(4): 303-309.
|
[34]
|
Jin, T., Ding, Q., Huang, H., Xu, D., Jiang, Y., Zhou, B., et al. (2012) PAQR10 and PAQR11 Mediate Ras Signaling in the Golgi Apparatus. Cell Research, 22, 661-676. https://doi.org/10.1038/cr.2011.161
|
[35]
|
Sathornsumetee, S., Rich, J.N. and Reardon, D.A. (2007) Diagnosis and Treatment of High-Grade Astrocytoma. Neurologic Clinics, 25, 1111-1139. https://doi.org/10.1016/j.ncl.2007.07.004
|
[36]
|
Louis, D.N., Ohgaki, H., Wiestler, O.D., et al. (2007) The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathologica, 114, 97-109. https://doi.org/10.1007/s00401-007-0243-4
|
[37]
|
吴淳. miR-140抑制胶质瘤细胞株U251、U87增殖和侵袭性的实验研究[D]: [硕士学位论文]. 苏州: 苏州大学, 2015: 1-55.
|
[38]
|
杨浩. miR-140-5p通过靶向调节TGFBR1和FGF9抑制肝细胞癌增殖和侵袭转移[D]: [博士学位论文]. 长沙: 中南大学, 2013.
|
[39]
|
韦尉元, 曹稳珑, 张笑石, 等. miRNA-1284在胃癌中的表达及其作用机制研究[J]. 中国病理生理杂志, 2015, 31(3): 440-446.
|
[40]
|
王显艳, 高峰, 赵春明, 孙玉荣, 温秋婷, 于秀文, 张晓杰. miR-140在人胃癌组织中的表达及对SGC-7901胃癌细胞功能的影响[J]. 中国病理生理杂志, 2016, 32(4): 651-657.
|
[41]
|
刘玲丽. miR-140在骨肉瘤中表达及功能的初步研究[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2015.
|
[42]
|
Song, B., Wang, Y., Xi, Y., et al. (2009) Mechanism of Chemoresistance Mediated by miR-140 in Human Osteosarcoma and Colon Cancer Cell. Oncogene, 28, 4065-4074. https://doi.org/10.1038/onc.2009.274
|
[43]
|
Pais, H., Nicolas, F.E., Soond, S.M., et al. (2010) Analyzing mRNA Expression Identifies Smad3 as a microRNA-140 Target Regulated Only at Protein Level. RNA, 16, 489-494. https://doi.org/10.1261/rna.1701210
|
[44]
|
赵文月, 邹佳芮, 王波, 范盼红, 毛俊, 李嘉芝, 刘涵, 肖晶, 马威. miR-140通过下调Smad3表达抑制结肠癌细胞迁移和侵袭能力[J]. 中华肿瘤杂志, 2014, 36(10): 739-745.
|
[45]
|
Ling, H., Ai, J., Hui, L., et al. (2016) Integrative miRNA and Gene Profiling Data Analysis Reveals Novel Biomarkers and Mechanisms for Lung Cancer. Oncotarget, 7, 8441-8454.
|
[46]
|
https://www.mycancergenome.org/content/disease/lung-cancer/
|
[47]
|
Bethune, G., Bethune, D., Ridgway, N. and Xu, Z. (2011) Epidermal Growth Factor Receptor (EGFR) in Lung Cancer: An Overview and Update. Journal of Thoracic Disease, 2, 48-51.
|
[48]
|
Langenfeld, E., Hong, C.C., Lanke, G. and Langenfeld, J. (2013) Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines. PLoS ONE, 8, e61256.
https://doi.org/10.1371/journal.pone.0061256
|
[49]
|
Hao, J., Lee, R., Chang, A., Fan, J., Labib, C., Parsa, C., Orlando, R., Andresen, B. and Huang, Y. (2014) DMH1, a Small Molecule Inhibitor of BMP Type I Receptors, Suppresses Growth and Invasion of Lung Cancer. PLoS ONE, 9, e90748. https://doi.org/10.1371/journal.pone.0090748
|